Is Bladder Cancer Hereditary?

Bladder cancer is one of the most common cancers, especially among older adults. If a family member has been diagnosed with it, you might wonder whether it’s something you could inherit too.

Understanding the role of genetics in bladder cancer can help you stay informed and make smart decisions about your health.

What is bladder cancer?

Bladder cancer begins when cells in the bladder lining start growing abnormally. These cells can eventually form tumours, which may spread to other areas if not treated early. Most cases start in the urothelial cells, which line the inside of the bladder.

This type of cancer is more common in men and typically affects people over 55. In the UK, about 10,000 new cases are diagnosed each year, making it one of the top ten most prevalent cancers in the country.

Can bladder cancer be inherited?

In most cases, bladder cancer is not directly inherited in the same way conditions like cystic fibrosis or Huntington’s disease are. However, there can still be a hereditary component in certain cases.

Some people inherit genetic changes from their parents that slightly increase their chances of developing cancer. These inherited changes do not guarantee a diagnosis, but they can raise your overall risk.

While the cancer itself is not typically passed down, an increased vulnerability to it might be.

The role of family history in developing bladder cancer

If you have a close relative with bladder cancer, such as a parent or sibling, your risk may be slightly higher than average. This may be due to shared genes, environmental exposures, or similar lifestyle choices such as smoking.

Some inherited syndromes, like Lynch syndrome or Cowden syndrome, can increase the risk of multiple cancers, including bladder cancer. However, these syndromes are rare.

Doctors usually only consider family history as a strong risk factor if multiple relatives have had related cancers or if they were diagnosed at a younger-than-usual age.

Genes linked to bladder cancer

A few specific genetic changes may raise the likelihood of bladder cancer. Researchers have identified variations in genes like NAT2 and GSTM1, which are involved in how the body breaks down harmful substances. 

People with certain versions of these genes may not clear carcinogens as efficiently, which could increase cancer risk if they’re exposed to smoking or industrial chemicals.

It’s important to note that these genetic changes are just one part of the picture. Most people with these variations never develop bladder cancer.

Lifestyle and environmental risks

Even if you have a genetic predisposition, your lifestyle plays a major role in whether you develop bladder cancer.

Smoking is the biggest known risk factor. Around half of all cases are linked to tobacco use. Harmful substances in cigarettes are filtered through the kidneys and end up in the bladder, where they can damage the lining over time.

Exposure to certain workplace chemicals used in the dye, rubber, and plastics industries can also increase risk, especially with long-term contact.

Other contributors include:

  • Long-term bladder infections
  • Certain medications or herbal supplements
  • Drinking water with high levels of arsenic

If you have a family history and are also exposed to one or more of these factors, your combined risk may be higher.

Signs and symptoms to watch for

Whether you have a family history or not, early detection is important. The most common symptom is blood in your urine, which might appear pink, red, or brown. Other signs include:

  • Pain or burning when urinating
  • Needing to pass urine more frequently
  • Feeling like your bladder is not fully empty
  • Pelvic pain or back discomfort

These symptoms do not always mean you have cancer, but they should never be ignored. If you notice anything unusual, speak to your GP.

Screening and monitoring for high-risk individuals

There is no routine screening programme for bladder cancer like there is for bowel or cervical cancer. However, if you are considered high-risk because of family history or exposure to chemicals, your doctor may recommend regular urine tests or cystoscopy checks.

Staying aware of changes in your body and reporting symptoms early can make a major difference in outcomes.

Can you reduce your risk?

While you cannot change your genes, there are steps you can take to lower your chances of developing bladder cancer:

  • Stop smoking if you currently smoke
  • Use protective equipment if you work with hazardous chemicals
  • Drink plenty of water to help flush your bladder
  • Eat a balanced diet rich in fruit and vegetables
  • Get regular check-ups if you’re considered at risk

These small changes can help limit your exposure to known triggers, which is especially important if you already have a family link.

Key takeaways

Bladder cancer is not usually inherited in the same way as some other conditions. However, a family history can still raise your risk slightly, especially when combined with lifestyle or environmental factors. Knowing your family medical history and making healthy choices can help you stay in control of your wellbeing.

Related guide: Can Bladder Cancer Return After Bladder Removal?

Picture of Maneesh Ghei
Maneesh Ghei
Mr Maneesh Ghei MS MRCSEd MD (UCL) FRCS (Urol) is a highly experienced Consultant Urological Surgeon and founder of Urocare London, with over three decades of practice in both NHS and private settings across the capital. As Lead Cancer Clinician at Whittington Hospital, Archway, he chairs the multidisciplinary urology cancer meeting, overseeing patient care from diagnosis through to the latest minimally invasive treatments. A pioneer in complex endourology and stone disease management, Mr Ghei led the UK’s first randomised, double-blind trial of intradetrusor botulinum toxin for refractory overactive bladder. He holds an MBBS and MS in General Surgery from India, an MD from University College London, and undertook advanced fellowships in stone disease and laparoscopic surgery, culminating in his Fellowship of the Royal College of Surgeons (Urology). Committed to education and research, he supervises doctoral work in focal therapies and cryotherapy for prostate cancer and champions public awareness through annual Movember fundraising.
Scroll to Top